tert-butyl 3-(3-methylthiophene-2-carboxamido)pyrrolidine-1-carboxylate

Catalog No.: 
ACXFRP017
CAS No.: 
1420886-89-0
Molecular Formula: 
C15H22N2O3S
Molecular Weight: 
310.42
tert-butyl 3-(3-methylthiophene-2-carboxamido)pyrrolidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-butyl 3-(3-methylthiophene-2-carboxamido)pyrrolidine-1-carboxylate
IUPAC Nametert-butyl 3-(3-methylthiophene-2-carboxamido)pyrrolidine-1-carboxylate
Molecular FormulaC15H22N2O3S
Molecular Weight310.42
SMILESCC1=C(C(=O)NC2CCN(C(=O)OC(C)(C)C)C2)SC=C1
InChI KeyWZHFWDNNSKXSLY-UHFFFAOYSA-N
Synonym1-Pyrrolidinecarboxylic acid, 3-[[(3-methyl-2-thienyl)carbonyl]amino]-, 1,1-dimethylethyl ester
CAS No.1420886-89-0

Synthetic Route by SureRoute

1. ACXFRP017 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVHFQ381 route compound structure diagram
    ACVHFQ381186550-13-0In Stock
  2. Plus
  3. ACBOZS375 route compound structure diagram
    ACBOZS37523806-24-8In Stock
  4. Then
  5. ACXFRP017 route product structure diagram
    ACXFRP0171420886-89-0
Inquiry

2. ACXFRP017 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVHFQ381 route compound structure diagram
    ACVHFQ381186550-13-0In Stock
  2. Plus
  3. ACBAFT480 route compound structure diagram
    ACBAFT48061341-26-2In Stock
  4. Then
  5. ACXFRP017 route product structure diagram
    ACXFRP0171420886-89-0
Inquiry

3. ACXFRP017 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVHFQ381 route compound structure diagram
    ACVHFQ381186550-13-0In Stock
  2. Plus
  3. ACFRPB164 route compound structure diagram
    ACFRPB16481452-54-2In Stock
  4. Then
  5. ACXFRP017 route product structure diagram
    ACXFRP0171420886-89-0
Inquiry

Comments (0)